However, the abortive complexes promoted by TOP2 poisons can be rescued by the action of TDP2, so that variations in cellular TDP2 activity (natural or tumour-specific) can influence the clinical efficacy of these drugs, and are therefore an important determinant of response to chemotherapy in the individual patient and tumour. This evidence concerns the gene TOP2A and neoplasm.